Showing results (41-50 of 173) with videos related to

Sort By:
Pageof 18
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|December 3, 2014
Comprehensive phenotyping of regulatory T cells after liver transplantationAnna Gronert Álvarez, Paraskevi Fytili, Pothakamuri V Suneetha, et al.
BMC Cancer|July 24, 2015
The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletionChristoph Burdelski, Devi Menan, Maria Christina Tsourlakis, et al.
Cancers|April 23, 2022
Combined Targeting of AKT and mTOR Inhibits Tumor Formation of EpCAM+ and CD90+ Human Hepatocellular Carcinoma Cells in an Orthotopic Mouse ModelMohamed Moustafa, Katarzyna-Krystyna Dähling, Armin Günther, et al.
Pathology, Research and Practice|June 25, 2021
MUC5AC expression is linked to mucinous/endometroid subtype, absence of nodal metastasis and mismatch repair deficiency in ovarian cancerSebastian Dwertmann Rico, Barbara Schmalfeldt, Volkmar Müller, et al.
Cancer Investigation|June 18, 2021
Mesothelin is Commonly Expressed in Pancreatic Adenocarcinoma but Unrelated to Cancer AggressivenessSören Weidemann, Daniel Perez, Jakob R Izbicki, et al.
International Journal of Molecular Sciences|April 21, 2015
VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomyMaria Christina Tsourlakis, Puya Khosrawi, Philipp Weigand, et al.
Carcinogenesis|September 23, 2015
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parametersNathaniel Melling, Erik Thomsen, Maria Christina Tsourlakis, et al.
Urologic Oncology|May 12, 2015
Heterogeneity in D'Amico classification-based low-risk prostate cancer: Differences in upgrading and upstaging according to active surveillance eligibilityJonas Schiffmann, Philipp Wenzel, Georg Salomon, et al.
Oncotarget|April 1, 2015
HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomyCristina Villares Zabalza, Meike Adam, Christoph Burdelski, et al.
Molecular and Clinical Oncology|August 31, 2021
High mitochondrial content is associated with breast cancer aggressivenessPatrick Lebok, Katharina Schütt, Martina Kluth, et al.
Pageof 18